Jiangsu Nanfang Medical Net Asset Quality Index
Jiangsu Nanfang Medical net asset quality index. Jiangsu Nanfang Medical (603880) has a Net Asset Quality Index of 18.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥874.85 Million minus total liabilities of CN¥711.34 Million yields net assets of CN¥163.51 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Jiangsu Nanfang Medical shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Jiangsu Nanfang Medical (2012–2025)
Net asset quality index of Jiangsu Nanfang Medical from 2012 to 2025. This chart shows how Jiangsu Nanfang Medical's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the index stands at 18.7%, representing net assets of CN¥163.51 Million against total assets of CN¥874.85 Million CNY. Check Jiangsu Nanfang Medical (603880) strategic asset index to assess the company's strategic physical and investment asset allocation.
Jiangsu Nanfang Medical Net Asset Quality Index by Year (2012–2025)
Jiangsu Nanfang Medical net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Jiangsu Nanfang Medical from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Jiangsu Nanfang Medical.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 19.5% | CN¥181.17 Million | CN¥927.94 Million | CN¥746.77 Million | ▼ -7.4 pp |
| 2024 | 26.9% | CN¥284.41 Million | CN¥1.06 Billion | CN¥772.14 Million | ▼ -10.2 pp |
| 2023 | 37.1% | CN¥474.22 Million | CN¥1.28 Billion | CN¥803.11 Million | ▼ -5.5 pp |
| 2022 | 42.6% | CN¥621.48 Million | CN¥1.46 Billion | CN¥835.75 Million | ▼ -10.4 pp |
| 2021 | 53.0% | CN¥654.90 Million | CN¥1.24 Billion | CN¥580.29 Million | ▼ -12.3 pp |
| 2020 | 65.3% | CN¥700.80 Million | CN¥1.07 Billion | CN¥371.84 Million | ▲ +0.1 pp |
| 2019 | 65.3% | CN¥567.52 Million | CN¥869.60 Million | CN¥302.08 Million | ▼ -1.0 pp |
| 2018 | 66.2% | CN¥560.04 Million | CN¥845.81 Million | CN¥285.78 Million | ▲ +0.9 pp |
| 2017 | 65.3% | CN¥537.57 Million | CN¥822.96 Million | CN¥285.40 Million | ▲ +15.6 pp |
| 2016 | 49.7% | CN¥256.69 Million | CN¥516.55 Million | CN¥259.87 Million | ▲ +2.7 pp |
| 2015 | 47.0% | CN¥222.51 Million | CN¥473.37 Million | CN¥250.86 Million | ▼ -1.3 pp |
| 2014 | 48.3% | CN¥210.90 Million | CN¥437.01 Million | CN¥226.10 Million | ▲ +3.1 pp |
| 2013 | 45.2% | CN¥168.57 Million | CN¥373.35 Million | CN¥204.78 Million | ▲ +13.2 pp |
| 2012 | 32.0% | CN¥121.38 Million | CN¥379.79 Million | CN¥258.41 Million | — |